ArticleFrontiers in oncology2025
An interpretable XAI deep EEG model for schizophrenia diagnosis using feature selection and attention mechanisms.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Configurable Modular EEG Classification Framework with Multiscale Features and Ensemble Learning: A Reproducible Evaluation for Schizophrenia Detection.Bioengineering (Basel, Switzerland) · 2026Article
- Using Artificial Intelligence to Develop Clinical Decision Support Systems-The Evolving Road of Personalized Oncologic Therapy.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Schizophrenia is a severe psychological disorder that significantly impacts an individual's life and is characterized by abnormalities in perception, behavior, and cognition. Conventional Schizophrenia diagnosis techniques are time- consuming and prone to error. The study proposes a novel automated technique for diagnosing Schizophrenia based on electroencephalogram (EEG) sensor data, aiming to enhance interpretability and prediction performance. Methods: This research utilizes Deep Learning (DL) models, including the Deep Neural Network (DNN), Bi-Directional Long Short-Term Memory-Gated Recurrent Unit (BiLSTM- GRU), and BiLSTM with Attention, for the detection of Schizophrenia based on EEG data. During preprocessing, SMOTE is applied to address the class imbalance. Important EEG characteristics that influence model decisions are highlighted by the interpretable BiLSTM-Attention model using attention weights in conjunction with SHAP and LIME explainability tools. In addition to fine-tuning input dimensionality, F-test feature selection increases learning efficiency. Results: Through the integration of feature importance analysis and conventional performance measures, this study presents valuable insights into the discriminative neurophysiological patterns associated with Schizophrenia, advancing both diagnostic and neuroscientific expertise. The experiment's findings show that the BiLSTM with attention mechanism model provides and accuracy of 0.68%. Discussion: The results show that the recommended approach is useful for Schizophrenia diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.